Indeed, TCGA analysis of right-sided CRC patients with high CD8 and high CD103 compared to the low CD8 low CD103 had significantly more immune pathway involvement than patients with left-sided tumours, suggesting greater immune responses in right-sided disease. The gene discussed is CD8A; the disease is colorectal carcinoma.